AdaptHealth (AHCO) Cash from Financing Activities (2018 - 2026)

AdaptHealth's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $52.6 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 193.8% year-over-year to $52.6 million; the TTM figure through Mar 2026 stood at -$193.6 million (up 34.66% YoY), while the FY2025 annual figure was -$302.2 million, down 51.89% from the prior year.
• Cash from Financing Activities was $52.6 million for Q1 2026 at AdaptHealth, up from -$32.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $52.6 million in Q1 2026 to a low of -$156.6 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged -$35.7 million across 5 years, with a median of -$32.9 million in 2025.
• Biggest YoY gain for Cash from Financing Activities was 828.28% in 2024; the steepest drop was 458.1% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$15.6 million in 2022, then slumped by 181.32% to -$43.9 million in 2023, then retreated by 23.06% to -$54.0 million in 2024, then soared by 38.98% to -$32.9 million in 2025, then soared by 259.58% to $52.6 million in 2026.
• The last three Cash from Financing Activities figures came in at $52.6 million (Q1 2026), -$32.9 million (Q4 2025), and -$56.6 million (Q3 2025), per Business Quant data.